Skip to main content
Clinical Trials/NCT01986374
NCT01986374CompletedNot Applicable

Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation

Servy Massey Fertility Insititute1 site in 1 country75 target enrollmentStarted: June 2013Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
75
Locations
1
Primary Endpoint
HCG enhances pregnancy rate

Study Overview

Brief Summary

The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest that placing HCG into the uterus prior to embryo transfer can enhance implantation.

Detailed Description

The study is in pilot phase, uncontrolled. The risks appear to be minimal and there are conflicting new reports being announced.

A small amount of fluid with HCG is injected into the uterus. HCG is a potent signal to the uterus for preparation for implantation.

This is not a funded study. Three published studies suggest the approach is valid; one refutes the concept.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 47 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • infertility patients undergoing IVF with good expectation of two embryos day 3 or day
  • must speak and read English. Includes donor eggs.

Exclusion Criteria

  • abnormal uterus

Arms & Interventions

HCG is introduced with small catheter.

Experimental

phase 1 non randomized pilot

Intervention: HCG is introduced (Drug)

Outcomes

Primary Outcomes

HCG enhances pregnancy rate

Time Frame: 9 months.

compare pregnancy rates to established clinical norms.

Secondary Outcomes

  • ongoing pregnancy rate(22 months)
  • implantation rate(18 months)

Investigators

Sponsor
Servy Massey Fertility Insititute
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials